Vitality Watch

Dossier pubmed review 14-nov-2026
Narrative review or expert overview without new data

Beyond Hematopoiesis: How Immune Are Hematopoietic Stem Cells?

Key claim: Hematopoietic stem cells actively sense inflammatory signals and undergo lasting epigenetic reprogramming, but chronic activation causes replicative stress, myeloid bias, and clonal selection that drive inflammaging and CHIP.

Abstract

Hematopoietic stem cells (HSCs) have traditionally been viewed primarily as quiescent cells responsible for maintaining blood production, with their function defined largely by the progeny they generate. This view has changed considerably with growing evidence that HSCs actively sense and respond to inflammatory signals. HSCs express pattern-recognition receptors and diverse cytokine receptors, allowing them to detect infection and sterile inflammation directly or through signals from the bone-marrow niche. In response, HSCs can exit quiescence, alter their differentiation toward the myeloid lineage, and support emergency hematopoiesis. Increasing evidence also suggests that inflammatory encounters can induce lasting epigenetic and metabolic changes in HSCs, shaping their subsequent responses and those of their progeny, a phenomenon associated with central trained immunity. HSCs can also express MHC class II and present antigen, suggesting functions beyond conventional stem-cell maintenance. However, immune responsiveness may also compromise HSC integrity. Acute, chronic, or repeated inflammatory exposure can induce replicative and metabolic stress, promote myeloid bias, alter clonal dynamics, and impair long-term self-renewal. Such changes may contribute to inflammaging and the development or expansion of clonal hematopoiesis of indeterminate potential (CHIP). In this review, we synthesise evidence from experimental studies and recent literature to examine the emerging immune functions of HSCs and their consequences for stem-cell maintenance. We propose that HSCs should be viewed not as inert progenitors or conventional immune effector cells, but as immune-responsive stem cells that sense inflammatory challenges, adapt their behaviour, and influence the output and function of the innate immune system. TEASER ABSTRACT: Hematopoietic stem cells (HSCs) are increasingly recognised as active responders to inflammation rather than passive precursors of immune cells. They sense inflammatory signals, adapt proliferation and lineage output, and retain epigenetic and metabolic memory that can shape subsequent haematopoiesis. However, chronic inflammation can impose replicative stress, impair self-renewal, and promote clonal selection and ageing. This review proposes that HSCs are best viewed as immune-responsive stem cells linking inflammatory sensing and adaptive haematopoiesis to both trained immunity and long-term stem-cell vulnerability.

Why this matters

[expert-opinion] This review places hematopoietic stem cells within the inflammatory sensing-and-memory network, connecting stem-cell stress, altered immune-cell production, and CHIP-associated clonal selection rather than treating them as separate aging processes. [expert-opinion] It extends the mechanistic account of how inflammation may become persistent, but adds no new primary evidence that interrupting this proposed circuit improves human immune function or healthspan.

Source

Link

Briefing card

Beyond Hematopoiesis: How Immune Are Hematopoietic Stem Cells?
Stage: review · pubmed · 14-nov-2026

Hematopoietic stem cells actively sense inflammatory signals and undergo lasting epigenetic reprogramming, but chronic activation causes replicative stress, myeloid bias, and clonal selection that drive inflammaging and CHIP.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.exphem.2026.105967

build build 880 · 2bcef25 · 2026-11-18